Regression of cardiac wall thickness following chemotherapy and stem cell transplantation for light chain (AL) amyloidosis

H. K. Meier-EwertAmyloid Treatment and Research Program, Boston University School of Medicine and Boston Medical Center, Boston, MA, USA

V. SanchorawalaAmyloid Treatment and Research Program, Boston University School of Medicine and Boston Medical Center, Boston, MA, USA

J. BerkAmyloid Treatment and Research Program, Boston University School of Medicine and Boston Medical Center, Boston, MA, USA

K. T. FinnAmyloid Treatment and Research Program, Boston University School of Medicine and Boston Medical Center, Boston, MA, USA

M. SkinnerAmyloid Treatment and Research Program, Boston University School of Medicine and Boston Medical Center, Boston, MA, USA

D. C. SeldinAmyloid Treatment and Research Program, Boston University School of Medicine and Boston Medical Center, Boston, MA, USA

F. L. RubergAmyloid Treatment and Research Program, Boston University School of Medicine and Boston Medical Center, Boston, MA, USA

show all

References

Falk RH, Dubrey SW. Amyloid heart disease. Prog Cardiovasc Dis 2010;52:347–361.
PubMed Web of Science ®Google Scholar
Sanchorawala V, Skinner M, Quillen K, Finn KT, Doros G, Seldin DC. Long-term outcome of patients with AL amyloidosis treated with high-dose melphalan and stem cell transplantation. Blood 2007;110:3561–3563.
PubMed Web of Science ®Google Scholar
Blair JEA, Zeigler SM, Mehta J, Singhal S, Cotts W. Regression of cardiac amyloid after autologous stem-cell transplantation. J Heart Lung Transplant 2009;28:746–748.
PubMed Web of Science ®Google Scholar
Ruberg RL, Sanchorawala V, Berk J, Finn KT, Skinner M, Seldin DC, Meier-Ewert H. Reduction in ventricular wall thickness following high-dose chemotherapy and stem-cell transplantation for AL cardiac amyloidosis. J Am Coll Cardiol 2010;55:A36.
Google Scholar
Gertz MA, Comenzo R, Falk RH, Fermand JP, Hazenberg BP, Hawkins PN, Merlini G, Moreau P, Ronco P, Sanchorawala V, Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th international symposium on amyloid and amyloidosis. Am J Hematol 2005;79:319–328.
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Regression of cardiac wall thickness following chemotherapy and stem cell transplantation for light chain (AL) amyloidosis

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Regression of cardiac wall thickness following chemotherapy and stem cell transplantation for light chain (AL) amyloidosis

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date